Next Article in Journal
Exploring Real World Outcomes with Nivolumab Plus Ipilimumab in Patients with Metastatic Extra-Pulmonary Neuroendocrine Carcinoma (EP-NEC)
Next Article in Special Issue
Oncological Safety and Recurrence in the Surgical Treatment of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma of the Scalp
Previous Article in Journal
Dyslipidemia in Children Treated with a BRAF Inhibitor for Low-Grade Gliomas: A New Side Effect?
Previous Article in Special Issue
Telomere as a Therapeutic Target in Dedifferentiated Liposarcoma
 
 
Review

Article Versions Notes

Cancers 2022, 14(11), 2694; https://doi.org/10.3390/cancers14112694
Action Date Notes Link
article pdf uploaded. 29 May 2022 16:56 CEST Version of Record https://www.mdpi.com/2072-6694/14/11/2694/pdf-vor
article xml file uploaded 31 May 2022 07:46 CEST Original file -
article xml uploaded. 31 May 2022 07:46 CEST Update -
article pdf uploaded. 31 May 2022 07:46 CEST Updated version of record https://www.mdpi.com/2072-6694/14/11/2694/pdf-vor
article html file updated 31 May 2022 07:48 CEST Original file -
article xml file uploaded 31 May 2022 08:42 CEST Update -
article xml uploaded. 31 May 2022 08:42 CEST Update https://www.mdpi.com/2072-6694/14/11/2694/xml
article pdf uploaded. 31 May 2022 08:42 CEST Updated version of record https://www.mdpi.com/2072-6694/14/11/2694/pdf
article html file updated 31 May 2022 08:44 CEST Update -
article html file updated 31 May 2022 10:07 CEST Update -
article html file updated 3 August 2022 02:33 CEST Update https://www.mdpi.com/2072-6694/14/11/2694/html
Back to TopTop